CORC  > 中国医学科学院 北京协和医学院
Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial
Guan Zhongzhen; Xu Jianming; Luo Rongcheng; Feng Fengyi; Wang Liwei; Shen Lin; Yu Shiying; Ba Yi; Liang Jun; Wang Dong
2011
卷号30期号:10页码:682-689
关键词Bevacizumab Chemotherapy First-line treatment Chinese patients Metastatic colorectal cancer
URL标识查看原文
收录类别CSCD
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6725556
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Guan Zhongzhen,Xu Jianming,Luo Rongcheng,et al. Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial[J],2011,30(10):682-689.
APA Guan Zhongzhen.,Xu Jianming.,Luo Rongcheng.,Feng Fengyi.,Wang Liwei.,...&Xu Ruihua.(2011).Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial.,30(10),682-689.
MLA Guan Zhongzhen,et al."Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial".30.10(2011):682-689.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace